Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19403903 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ribavirin;   Drug: Pegylated Interferon Alfa 2a;   Drug: Placebo;   Drug: Telaprevir

Indicates status has not been verified in more than two years